Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 443

1.

Quality of life in lung cancer patients: as an important prognostic factor.

Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR.

Lung Cancer. 2001 Feb-Mar;31(2-3):233-40.

PMID:
11165402
2.

Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.

Ozturk A, Sarihan S, Ercan I, Karadag M.

Am J Clin Oncol. 2009 Feb;32(1):65-72. doi: 10.1097/COC.0b013e31817e6ec2.

PMID:
19194128
3.

Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma?

Herndon JE 2nd, Fleishman S, Kornblith AB, Kosty M, Green MR, Holland J.

Cancer. 1999 Jan 15;85(2):333-40.

PMID:
10023700
4.

How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer.

Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR.

Qual Life Res. 2003 Mar;12(2):157-66.

PMID:
12639062
5.

The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy.

Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M.

Radiother Oncol. 2000 Apr;55(1):19-25.

PMID:
10788684
6.

Quality of life measures (EORTC QLQ-C30 and SF-36) as predictors of survival in palliative colorectal and lung cancer patients.

Grande GE, Farquhar MC, Barclay SI, Todd CJ.

Palliat Support Care. 2009 Sep;7(3):289-97. doi: 10.1017/S1478951509990216. Erratum in: Palliat Support Care. 2009 Dec;7(4):533.

PMID:
19788770
8.

Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial.

Paccagnella A, Favaretto A, Oniga F, Barbieri F, Ceresoli G, Torri W, Villa E, Verusio C, Cetto GL, Santo A, De Pangher V, Artioli F, Cacciani GC, Parodi G, Soresi F, Ghi MG, Morabito A, Biason R, Giusto M, Mosconi P, Chiarion Sileni V; GSTVP (Gruppo di Studio Tumori Polmonari del Veneto).

Lung Cancer. 2004 Jan;43(1):83-91.

PMID:
14698542
9.

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al.

J Natl Cancer Inst. 1993 Mar 3;85(5):365-76.

PMID:
8433390
10.

Quality of life after stereotactic radiotherapy for stage I non-small-cell lung cancer.

van der Voort van Zyp NC, Prévost JB, van der Holt B, Braat C, van Klaveren RJ, Pattynama PM, Levendag PC, Nuyttens JJ.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):31-7. doi: 10.1016/j.ijrobp.2009.04.080. Epub 2009 Oct 26.

PMID:
19864077
11.

Preoperative psychological global well being index (PGWBI) predicts postoperative quality of life for patients with non-small cell lung cancer managed with thoracic surgery.

Barlési F, Doddoli C, Loundou A, Pillet E, Thomas P, Auquier P.

Eur J Cardiothorac Surg. 2006 Sep;30(3):548-53. Epub 2006 Jul 24.

PMID:
16860566
12.
13.

Efficient palliation in patients with small-cell lung cancer by a combination of paclitaxel, etoposide and carboplatin: quality of life and 6-years'-follow-up results from a randomised phase III trial.

Reck M, von Pawel J, Macha HN, Kaukel E, Deppermann KM, Bonnet R, Ulm K, Hessler S, Gatzemeier U.

Lung Cancer. 2006 Jul;53(1):67-75. Epub 2006 May 19.

PMID:
16713013
14.
15.
16.

Validity of the Assessment of Quality of Life (AQoL) utility instrument in patients with operable and inoperable lung cancer.

Manser RL, Wright G, Byrnes G, Hart D, Conron M, Carter R, McLachlan SA, Campbell DA.

Lung Cancer. 2006 Aug;53(2):217-29. Epub 2006 Jun 12.

PMID:
16765475
17.
18.

Does marital status impact survival and quality of life in patients with non-small cell lung cancer? Observations from the mayo clinic lung cancer cohort.

Jatoi A, Novotny P, Cassivi S, Clark MM, Midthun D, Patten CA, Sloan J, Yang P.

Oncologist. 2007 Dec;12(12):1456-63. doi: 10.1634/theoncologist.12-12-1456.

19.

Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.

Sundstrøm S, Bremnes R, Aasebø U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S.

J Clin Oncol. 2004 Mar 1;22(5):801-10.

PMID:
14990635
20.

Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.

Brown J, Thorpe H, Napp V, Fairlamb DJ, Gower NH, Milroy R, Parmar MK, Rudd RM, Spiro SG, Stephens RJ, Waller D, West P, Peake MD.

J Clin Oncol. 2005 Oct 20;23(30):7417-27. Epub 2005 Sep 12.

PMID:
16157935

Supplemental Content

Support Center